Blood Products Advisory Committee
March 25-26, 1999
Date and Time
The meeting will be held on March 25-26, 1999, beginning at 8:00 am on both days.
Location
Bethesda Ramada Inn, 8400 Wisconsin Avenue, Bethesda, MD.
Contact Person
Linda A. Smallwood, Ph.D., 301-827-3514, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 19516. Please call the Information Line for up-to-date information on this meeting.
Oral Presentations
On March 25, 1999, oral presentations from the public will be scheduled between approximately 10:30 to 11:00 am, 1:30 to 2:00 pm, and 4:30 to 5:00 pm. On March 26, 1999, presentations will be scheduled between approximately 8:45 to 9:15 am, and 11:30 am to 12:00 noon. Those desiring to make formal oral presentations should notify the contact person before March 15, 1999.
Agenda
On March 25, 1999, in the morning, the Committee will hear, discuss, and provide comments on an informational presentation on Nucleic Acid Testing of Whole Blood. In the afternoon, the Committee will discuss and provide comments on Human Immunodeficiency Virus (HIV) p24 Antigen Testing and Validation of Donor History Questions. On March 26, 1999 the Committee will discuss and provide comment on an informational presentation on Clinical Trial Endpoints for Immune Globulin Intravenous (IGIV) and will discuss and provide recommendations on algorithms to address Inadvertent Contamination (with HIV, HBsAg, and/or HCV) of Plasma Pools for Fractionation.